![]() |
The market debate now is whether this latest little leg up is due for a breather. My system is leaning toward more short-term strength, but it's tough to feel confident when the technicals I've been relying on have been whipsawed so frequently in the past month.
I've suggested in past columns that in the wake of my insider buy/sell ratios falling off a cliff back in July 2003, a different interpretation of what level indicates bullishness may be necessary. It used to be that only inflection points downward after the ratios hit a level of positive 20% or more (indicating 20% more companies with open-market purchases than sales) indicated a solid buy signal for the indices. While I do expect my ratios to act normally again when the various economic imbalances around the world normalize as well, they haven't yet. Therefore, I have to be open to the possibility that the present level of the ratios may once again be significant, given the odd economic time we are in. This is hardly a strong confirmation of a continuing leg up, however, and my present market call is once again back to one of "treacherous." The potential reward of acting overly bullish or bearish right now just doesn't appear worth the risk. Still, I've committed a little more capital to the market recently, lowering my cash balance to 50% from 60%. Given that still very high cash balance, I'm hardly advocating jumping headfirst into this rally. But I am emboldened to nibble at some of the value stocks that could benefit from a healthier market, and these value stocks should theoretically hold up better if indices turn down again soon.
VistaCare Outlook ClarifiedOne such value is VistaCare (VSTA - commentary - Cramer's Take). After I lowered the stock to a hold, the Medicare-related woes of this hospice provider just kept building.
Go to NEXT PAGE
At the time of publication, Moreland was long VistaCare, although holdings can change at any time. Jonathan Moreland is director of research and publisher of the weekly publication InsiderInsights, founder of the Web site InsiderInsights.com and the director of research at Insider Asset Management LLC. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.
Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||||||